Biolargo Inc

Welcome to BioLargo annual fourth quarter 2023 earning results conference call. At this time, all participants are in a listen-only mode. Anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note, this conference is being recorded. I would now like to turn the conference over to Brian Loper. You may begin.

Great. Thank you, operator. Good afternoon, everyone. Welcome to BioLargo's 2023 annual results conference call. By now, everyone should have had access to the earnings press release, which was issued prior to market open, and the 10-Q report filed at the SEC. This call is being webcast and is available for replay. In our remarks today, we may include statements that are considered forward-looking within the meanings of securities laws, including forward-looking statements about future results of operations, business strategies and plans, our relationships with our customers, market and potential growth opportunities. In addition, management may make additional forward-looking statements in response to your questions. Forward-looking statements are based on management's current knowledge and expectations as of today and are subject to certain risks and uncertainties and may cause the actual results to differ materially from the forward-looking statements. A detailed discussion of such risks and uncertainties are contained in our most recent Form 10-K, Form 10-Q, and in other reports filed at the SEC. The company undertakes no obligation to update any forward-looking statements. And with that, I now hand the call over to BioLargo's Chief Executive Officer, Dennis Calvert.

Hey, thank you, Brian. This is Dennis. Thank you, everyone, for joining us. We're going to cover quite a bit of territory. I also want to mention Charles Dargan, our CFO, has joined us as well. He'll be presenting some of the financial information and also available for Q&A. So just a real quick review of who we are and what we're doing, right? BioLargo, we make life better. It's a big calling. Focus on purposeful change. innovation to make a change for good, for clean air, clean water, and remember our strategy, invent it, prove it, and partner it. Partner for success. That's a critical component. So who are we, right? Well, safe harbors. Brian covered that. Covered that quite well. Innovators and scientists passionate about doing something important for sustainable innovation and human health, driven by this purpose, for best-in-class solutions, lots of engineering, heavy engineering emphasis, and focus on problems without solutions. We've been doing it now since the first acquisition of the BioLargo technology in the spring of 2007, and we have years of innovation and multiple platforms. We call the BioLargo engine the innovation engine. At the corporate office, we have deep engineering staff join us about five years ago, making significant contribution. Our company up in Canada is now called BioLargo Canada, heavily focused on R&D, recipient of over 100 grants, critical piece of the puzzle as well as we delve into some of these advanced developments for our technologies. I'm not going to cover all the details, but I do want to publish these details so that when you look back to it, you can see some of these notes. But the punchline is Clear Medical is really focused on product launch, and we've recently made some significant acquisitions of capital equipment for our contract manufacturer. Contract manufacturer, very critical. Clear has gone through the regulatory, the design, The complete safety protocol, QAQC, contracts out manufacturing. Very important. Contracts out manufacturing and then builds distribution through relationships. That's that partner component. And we're in the process now preparing for some significance. We've been talking about that for months. It's very close at hand and we're excited about the future for CLIRA. Energy. It's a new technology. We built a small manufacturing facility. We're making cells for testing. We're on a journey there. It's quite exciting. And we've got a number of partnerships that are in development stage. We'll talk about that in a minute. Of course, we can't miss O&M Environmental for our odor and our blockbuster relationship with Poof Inc. They continue to break records, a trend that's astonishing, and the financial results speak for themselves. They're just impeccable. And we heard just the other day they're calling it the fastest-growing odor-controlled product in the world, right? Anyway. Anyway. It's a lot of social media buzz on that product. It's incredible. They've done a great job. And then, of course, our water solutions company, right, BioLego Equipment Solutions and Technologies. This has now brought together all the innovations. We've got first customers in PFAS. We've got a significant robust pipeline. And all of our operating units support that enterprise as it commercializes those technologies. It's arduous, rich, and we think going to be significant. I'll now pass this to Charlie Dargan to talk about the results for the year and some of the commentary on that. Charles, why don't you step in here with me?